Search

Your search keyword '"Melissa, Hamilton"' showing total 7 results
Start Over Author "Melissa, Hamilton" Journal journal of the american college of cardiology
7 results on '"Melissa, Hamilton"'

1. SAFETY AND EFFECTIVENESS OF APIXABAN VERSUS WARFARIN IN THE TREATMENT AND PREVENTION OF VENOUS THROMBOEMBOLISM

Author

Derek Weycker, Mark Atwood, Xiaoyan Li, Jack Mardekian, Theodore Lee, Xuemei Luo, Melissa Hamilton, Lien Vo, Xianying Pan, Leah Burns, and Gail Wygant

Subjects
business.industry, Warfarin, Heparin, 030204 cardiovascular system & hematology, equipment and supplies, 03 medical and health sciences, 0302 clinical medicine, Anesthesia, medicine, Apixaban, cardiovascular diseases, 030212 general & internal medicine, Cardiology and Cardiovascular Medicine, business, Venous thromboembolism, Major bleeding, medicine.drug
Abstract

The AMPLIFY trial showed that apixaban was non-inferior to low-molecular-weight heparin followed by warfarin in the treatment of acute venous thromboembolism (VTE), and was associated with less bleeding. The purpose of this study was to compare risks of major bleeding and recurrent VTE with apixaban

Published
2018
Full Text
View/download PDF

2. COMPARISON OF EFFECTIVENESS, SAFETY, AND THE NET CLINICAL OUTCOME BETWEEN DIFFERENT DIRECT ORAL ANTICOAGULANTS IN 162,707 NON-VALVULAR ATRIAL FIBRILLATION PATIENTS TREATED IN US CLINICAL PRACTICE

Author

Anagha Nadkarni, Onur Baser, Xiaoyan Li, Jack Mardekian, Xuemei Luo, Xianying Pan, Melissa Hamilton, Allison Keshishian, Gregory Y.H. Lip, Kiran Gupta, Steve Deitelzweig, Keith Friend, and Cristina Masseria

Subjects
medicine.medical_specialty, business.industry, Non valvular atrial fibrillation, 030204 cardiovascular system & hematology, Health outcomes, medicine.disease, Clinical Practice, 03 medical and health sciences, Multiple data, 0302 clinical medicine, Pooled analysis, 030220 oncology & carcinogenesis, Medicine, Observational study, Generalizability theory, Cardiology and Cardiovascular Medicine, business, Intensive care medicine, Stroke
Abstract

Most observational studies on direct oral anticoagulants (DOACs) used single data sources with limited generalizability. This ARISTOPHANES (Anticoagulants for Reduction In STroke: Observational Pooled analysis on Health outcomes ANd Experience of patientS) study aimed to use multiple data sources to

Published
2018
Full Text
View/download PDF

3. COMPARISON OF ORAL ANTICOAGULANTS OR ANTIPLATELET THERAPY FOR THE EXTENDED TREATMENT OF VENOUS THROMBOEMBOLISM: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Author

Ander Cohen, S. Batson, Hemant Phatak, Cristina Masseria, Stephen Mitchell, and Melissa Hamilton

Subjects
Secondary prevention, medicine.medical_specialty, Aspirin, business.industry, law.invention, Randomized controlled trial, law, Meta-analysis, Internal medicine, medicine, business, Cardiology and Cardiovascular Medicine, Venous thromboembolism, medicine.drug
Abstract

A systematic review and network meta-analysis (NMA) were conducted to compare oral anticoagulants and aspirin for the secondary prevention of venous thromboembolism (VTE). Databases were searched (July 2014) to identify phase III randomized controlled trials (RCTs) evaluating the novel oral anti

Published
2015
Full Text
View/download PDF

4. VALIDATION OF THE APIXABAN COST-EFFECTIVENESS MODEL IN PATIENTS WITH VENOUS THROMBOEMBOLISM

Author

Robert Leipold, Alexander Cohen, Melissa Hamilton, Chantelle Browne, Cristina Masseria, Peter Quon, T. Lanitis, and Dale Rublee

Subjects
Predictive validity, medicine.medical_specialty, business.industry, Cost effectiveness, Markov model, Medicine, Apixaban, In patient, business, Intensive care medicine, Cardiology and Cardiovascular Medicine, Venous thromboembolism, Event (probability theory), medicine.drug
Abstract

To assess the predictive validity of apixaban cost-effectiveness model by comparing key event rates from model to those seen in AMPLIFY and AMPLIFY-EXT trials in patients with venous thromboembolism (VTE). Markov model was developed to extrapolate the observed clinical impact of apixaban versus

Published
2015
Full Text
View/download PDF

5. ORAL ANTICOAGULANT (OAC) UTILIZATION IN ATRIAL FIBRILLATION AFTER THE INTRODUCTION OF NOVEL ORAL ANTICOAGULANTS

Author

Sameer R. Ghate, Nassir F. Marrouche, Joseph Biskupiak, Melissa Hamilton, Diana I. Brixner, Sumesh Kachroo, Xianying Pan, and Xianchen Liu

Subjects
medicine.medical_specialty, business.industry, Internal medicine, Cardiology, Oral anticoagulant, Medicine, Atrial fibrillation, business, medicine.disease, Cardiology and Cardiovascular Medicine
Published
2014
Full Text
View/download PDF

6. REAL-WORLD COMPARISON OF INPATIENT BLEEDING RISK, BLEEDING-RELATED HOSPITALIZATION RATES AND COSTS AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS ON APIXABAN, DABIGATRAN, RIVAROXABAN: COHORTS COMPRISING NEW INITIATORS AND/OR SWITCHERS FROM WARFARIN

Author

Cristina Masseria, Melissa Hamilton, Ping Tepper, Younos Abdulsattar, Shital Kamble, William Petkun, Ruslan Horblyuk, Jack Mardekian, and Gregory Y.H. Lip

Subjects
medicine.medical_specialty, Rivaroxaban, business.industry, Non valvular atrial fibrillation, Warfarin, 030204 cardiovascular system & hematology, Dabigatran, 03 medical and health sciences, 0302 clinical medicine, Anesthesia, Emergency medicine, Medicine, Resource use, Apixaban, 030212 general & internal medicine, Cardiology and Cardiovascular Medicine, business, medicine.drug
Abstract

Information about the risk of bleeding and bleeding-related resource use and costs among non-Vitamin K antagonist oral anticoagulants (NOACs) in the real-world setting is scarce. This study aim was to compare inpatient bleeding risks, bleeding-related hospitalization rates and costs among non

Published
2016
Full Text
View/download PDF

7. HOSPITALIZATIONS, RECURRENT VENOUS THROMBOEMBOLISM OR VENOUS THROMBOEMBOLISM-RELATED DEATH, AND MAJOR BLEEDING, BY INDEX EVENT FROM THE AMPLIFY TRIAL

Author

Anthony R. Porcari, Alexander (Ander) Cohen, Cristina Masseria, Andrei Breazna, Jack Mardekian, Gregory DiRusso, Melissa Hamilton, Ruslan Horblyuk, and Theodore C. Lee

Subjects
medicine.medical_specialty, Index (economics), business.industry, 030503 health policy & services, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, medicine, 0305 other medical science, Cardiology and Cardiovascular Medicine, Intensive care medicine, business, Venous thromboembolism, Major bleeding, Event (probability theory)
Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results